Generic Drugs Market in Japan 2015-2019: New research report available at Fast Market Research

From: Fast Market Research, Inc.
Published: Fri Feb 20 2015

A generic drug is a duplicate of brand-name drugs and has the same dosage form, active ingredient(s), potency, route of administration, quality, and intended use as that of branded drugs. Generic drugs enter the market once the patent protection of the original developer expires. Generally, the cost of generic drugs is 50-70 percent lower than that of their brand-name counterparts, while meeting the very same standards of safety, quality, and efficacy as the innovator drugs. Generic drugs help the manufacturer by eliminating the need to develop and market a new drug. As the patent approaches expiration, manufacturers can apply to the FDA for approval to manufacture and sell generic versions of the drug. Generic drugs are equal to and within the bioequivalence range of branded drugs.

TechNavio's analysts forecast the Generic Drugs market in Japan to grow at a CAGR of 8.16 percent over the period 2014-2019.

Full Report Details at

Covered in this Report

The Generic Drugs market in Japan can be divided into three segments: Generic Prescription Medicines, Super Generics, and Biosimilars. This report covers the present scenario and the growth prospects of the Generic Drugs market in Japan for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the following segments:

* Generic Prescription Medicines
* Super Generics
* Biosimilars

TechNavio's report, the Generic Drugs market in Japan 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape of the Generic Drugs market in Japan and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Vendors

* Meiji Seika Pharma
* Nichi-Iko Pharmaceutical
* Nipro Pharma
* Sawai Pharmaceuticals
* Teva Pharmaceutical Industries
* Towa Pharmaceutical

Other Prominent Vendors

* Actavis
* Daiichi Sankyo
* Daito Pharmaceutical
* Eisai
* Fuji Pharma
* GlaxoSmithKline
* Hikari Pharmaceutical
* Hospira
* Mylan
* Nihon Generic
* Nippon Chemipher
* Nippon Kayaku
* Nissin Pharmaceutical
* Ohara Pharmaceutical
* Pfizer
* Sandoz
* Taiyo Yakuhin
* Takeda Pharmaceutical
* Zensei Pharmaceutical Industries

Market Driver

* Increase in Number of Patent Expiries
* For a full, detailed list, view our report.

Market Challenge

* Intense Competition among Vendors
* For a full, detailed list, view our report

Market Trend

* Increase in M&A
* For a full, detailed list, view our report

Key Questions Answered in this Report

* What will the market size be in 2019 and what will the growth rate be?

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Global Generic Drugs Market 2014-2018
- Generic Drugs: Global collaboration opportunities
- PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2023
- Global CRAMS Market Outlook to 2018 - India and China Present Bright Prospects
- PharmaPoint: Migraine - Global Drug Forecast and Market Analysis to 2023
Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email:
Contact Phone: 1-413-485-7001

Visit website »